Literature DB >> 383356

Gilbert's syndrome and drug metabolism.

A F Macklon, R L Savage, M D Rawlins.   

Abstract

Gilbert's syndrome is an inherited disorder which is characterised by unconjugated hyperbilirubinaemia. In patients with Gilbert's syndrome, both bilirubin clearance and in vitro hepatic microsomal uridine diphosphoglucuronyl transferase (UDPGT) activity are reduced. In addition, there is evidence suggesting impaired hepatic uptake of bilirubin in Gilbert's syndrome. Glucuronidation of a number of substrates appears to be impaired in Gilbert's syndrome, but the significance of the reported changes in oxidation and acetylation are less clear.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383356     DOI: 10.2165/00003088-197904030-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  43 in total

1.  Reduced caloric intake and nicontinic acid provocation tests in the diagnosis of Gilbert's syndrome.

Authors:  A R Davidson; A Rojas-Bueno; R P Thompson; R Williams
Journal:  Br Med J       Date:  1975-05-31

2.  Population studies on Gilbert's syndrome.

Authors:  D Owens; J Evans
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

3.  DEFECTS IN HEPATIC TRANSPORT OF BILIRUBIN IN CONGENITAL HYPERBILIRUBINAEMIA: AN ANALYSIS OF PLASMA BILIRUBIN DISAPPEARANCE CURVES.

Authors:  B H BILLING; R WILLIAMS; T G RICHARDS
Journal:  Clin Sci       Date:  1964-10       Impact factor: 6.124

4.  [The genetics of Gilbert syndrome].

Authors:  E Penner; W R Mayr; S Djawan; H Seyfried; M Pacher
Journal:  Schweiz Med Wochenschr       Date:  1976-06-19

5.  Definition of a conjugation of dysfunction in Gilbert's syndrome: studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile.

Authors:  C A Goresky; E R Gordon; E A Shaffer; P Paré; D Carassavas; A Aronoff
Journal:  Clin Sci Mol Med       Date:  1978-07

6.  An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium.

Authors:  L W Powell; B H Billing; H S Williams
Journal:  Australas Ann Med       Date:  1967-08

7.  Liver ultrastructure in Gilbert's syndrome.

Authors:  J O McGee; J G Allan; R I Russell; R S Patrick
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

8.  Effects of caloric and noncaloric materials in fasting hyperbilirubinemia.

Authors:  P V Barrett
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

9.  Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.

Authors:  A J Levi; Z Gatmaitan; I M Arias
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

10.  Hepatic accumulation and intracellular binding of conjugated bilirubin.

Authors:  A W Wolkoff; J N Ketley; J G Waggoner; P D Berk; W B Jakoby
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

View more
  5 in total

Review 1.  Clinically relevant genetic variations in drug metabolizing enzymes.

Authors:  Navin Pinto; M Eileen Dolan
Journal:  Curr Drug Metab       Date:  2011-06       Impact factor: 3.731

Review 2.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

3.  Antipyrine clearance in patients with Gilbert's syndrome.

Authors:  T Ishizaki; K Chiba; T Sasaki
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

Authors:  B Burchell; M W Coughtrie
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

5.  UGT1A1*28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients: Outcomes from a case-control study.

Authors:  Marcelo Moreira Tavares de Souza; Victor Van Vaisberg; Rodrigo Martins Abreu; Aline Siqueira Ferreira; Camila daSilvaFerreira; Paulo Dominguez Nasser; Helena Scavone Paschoale; Flair José Carrilho; Suzane Kioko Ono
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.